Human Molecular GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
Association of polygenic risk scores for coronary artery disease with subsequent events amongst established cases
Laurence J HoweiD, Frank DudbridgeiD, Amand Floriaan SchmidtiD, Chris FinaniD, Spiros DenaxasiD, Folkert Wouter AsselbergsiD, Aroon Dinesh HingoraniiD, Riyaz S. PateliD
Abstract
BackgroundThere is growing evidence that polygenic risk scores (PRS) can be used to identify individuals at high lifetime risk of coronary artery disease (CAD). Whether they can also be used to stratify risk of subsequent events among those surviving a first CAD event remains uncertain. MethodsUsing two subsamples of UK Biobank, defined at baseline as prevalent CAD (N=10,287) and without CAD (N=393,108), we evaluated associations between a CAD PRS and incident cardiovascular and fatal outcomes, during a median follow up of 7.8 years. ResultsA 1 S.D. higher PRS was associated with increased risk of incident MI in participants without CAD (OR 1.33; 95% C.I. 1.29, 1.38), but the effect estimate was markedly attenuated in those with prevalent CAD (OR 1.15; 95% C.I. 1.06, 1.25); heterogeneity P =0.0012. Additionally, among prevalent CAD cases, we found evidence of an inverse association between the CAD PRS and risk of all-cause death (OR 0.91; 95% C.I. 0.85, 0.98) compared to those without CAD (OR 1.01; 95% C.I. 0.99, 1.03); heterogeneity P =0.0041. A similar inverse association was found for ischaemic stroke (Prevalent CAD (OR 0.78; 95% C.I. 0.67, 0.90); without CAD (OR 1.09; 95% C.I. 1.04, 1.15), heterogeneity P <0.001). ConclusionsBias induced by case stratification and survival into UK Biobank may attenuate, or reverse, associations of polygenic risk scores derived from case-control studies or populations initially free of disease. Polygenic risk scores for subsequent events should be derived from new genome wide association studies conducted in patients with established disease. Key messagesO_LICAD PRS are positively associated with incident myocardial infarction risk amongst established CAD cases. C_LIO_LIHowever, the effect size is attenuated compared to estimates from CAD-free populations. C_LIO_LICAD PRS are inversely associated with mortality and stroke risk amongst established CAD cases. C_LIO_LIThese associations may reflect index event bias induced by stratifying on case status. C_LIO_LIDedicated GWAS of coronary disease progression are required to improve prediction of subsequent event risk. C_LI
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 38
- FWCI
- 3.51
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparison of polygenic risk scores for coronary artery disease highlights obstacles to overcome for clinical use
Holly Trochet, Justin Pelletier, … Julie Hussin·bioRxiv·Aug 9, 2020
- Validation of genome-wide polygenic risk scores for coronary artery disease in French Canadians
Florian Wünnemann, Ken Sin Lo, … Guillaume Lettre·Circulation Genomic and Precision MedicinePeer-reviewed·Jun 1, 2019
- An integrated polygenic and clinical risk tool enhances coronary artery disease prediction
Fernando Riveros-Mckay, Michael E. Weale, … Peter Donnelly·Circulation Genomic and Precision MedicinePeer-reviewed·Mar 2, 2021
- Prediction of incident coronary artery disease in individuals with zero coronary artery calcium using a novel multi-ancestry, label-free polygenic risk score framework
Giordano Bottà, Muriel Rossi, … Paolo Di Domenico·medRxiv·Mar 4, 2026
- Association of a polygenic risk score with coronary atherosclerotic burden in clinical CT angiograms
Katherine Hartmann, Michael P. Gannon, … Michael G. Levin·medRxiv·May 27, 2026
- Broad Clinical Manifestations of Polygenic Risk for Coronary Artery Disease in the Women's Health Initiative
Shoa L. Clarke, Matthew J. Parham, … Themistocles L. Assimes·Communications MedicinePeer-reviewed·Aug 25, 2022